Series B funding round for Mineralys Therapeutics raising $120M in June 2022
Series B funding round for Mineralys Therapeutics raising $120M in June 2022
| Investor | Firm Type | Partner |
|---|
| Private | — | |
Andera PartnersLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$120M
Top Valuation
-
Mineralys Therapeutics raised $120M in a Series B round.
The round was announced on 06/01/22.
The round was led by Andera Partners, Derek DiRocco.